Written by Tahir Amin

The Folly of Hoarding Knowledge in the COVID-19 Age

Let Vaccine Producers in Poor Countries Help End the Pandemic (Foreign Affairs, January 2021)

Read It
Innovation alone won’t end COVID-19

(Nature, January 2022)

Read It
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of Covid-19 and Future Pandemic Preparedness

(Sage Journals, September 2022)

Read It
Think "Squid Game" is Scary? Our Real Life Vaccine Inequity is Worse

(Medium, October 2021)

Read It
Big Pharma's Patent Abuses are Fueling the Drug Pricing Crisis

(TIME, February 2023)

Read It
TrumpRx and a most favored nation policy won’t lower prices for patients

(STAT, October 2025)

Read It
At the Mercy of Big Pharma

A new book explains why drugs cost so much in the United States — and why Trump’s claims about addressing the crisis are bogus (May 2026)

Read it
Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.

(MarketWatch, May 2026)

Click Here
‘Free markets’ and shackled access to medicines

(The Hindu Businessline, May 2026)

Click Here

Podcast Interviews & Features with Tahir

New York Times - The Argument

Could Spilling Big Pharma’s Secrets Vaccinate the World?

LISTEN
Pitchfork Economics with Nick Hanauer

Vaccine development needs new incentives

LISTEN
Radical x Change(s)

On a More Just and Equitable Approach to Intellectual Property

LISTEN
Forbes

Interview/book feature

Click Here